| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial.
|
Lancet
|
2010
|
8.52
|
|
2
|
Malaria.
|
Lancet
|
2005
|
7.37
|
|
3
|
Manslaughter by fake artesunate in Asia--will Africa be next?
|
PLoS Med
|
2006
|
4.46
|
|
4
|
A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease.
|
Nat Med
|
2004
|
2.93
|
|
5
|
Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data.
|
Lancet Infect Dis
|
2013
|
2.00
|
|
6
|
A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adults.
|
PLoS Med
|
2004
|
1.70
|
|
7
|
Protective efficacy of the RTS,S/AS02 Plasmodium falciparum malaria vaccine is not strain specific.
|
Am J Trop Med Hyg
|
2003
|
1.45
|
|
8
|
Predicting the clinical outcome of severe falciparum malaria in african children: findings from a large randomized trial.
|
Clin Infect Dis
|
2012
|
1.39
|
|
9
|
Imputation-based meta-analysis of severe malaria in three African populations.
|
PLoS Genet
|
2013
|
1.25
|
|
10
|
A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.
|
PLoS One
|
2012
|
1.24
|
|
11
|
Low-level malaria infections detected by a sensitive polymerase chain reaction assay and use of this technique in the evaluation of malaria vaccines in an endemic area.
|
Am J Trop Med Hyg
|
2007
|
1.20
|
|
12
|
Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults.
|
PLoS One
|
2013
|
1.09
|
|
13
|
Prognostic value of circulating pigmented cells in African children with malaria.
|
J Infect Dis
|
2009
|
1.09
|
|
14
|
A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine.
|
BMC Med
|
2014
|
1.07
|
|
15
|
The Lambaréné Organ Dysfunction Score (LODS) is a simple clinical predictor of fatal malaria in African children.
|
J Infect Dis
|
2009
|
1.07
|
|
16
|
To assess whether indoor residual spraying can provide additional protection against clinical malaria over current best practice of long-lasting insecticidal mosquito nets in The Gambia: study protocol for a two-armed cluster-randomised trial.
|
Trials
|
2011
|
1.07
|
|
17
|
Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adults.
|
J Infect Dis
|
2003
|
1.07
|
|
18
|
Variation in Toll-like receptor 4 and susceptibility to group A meningococcal meningitis in Gambian children.
|
Pediatr Infect Dis J
|
2003
|
0.99
|
|
19
|
Malaria in infants aged less than six months - is it an area of unmet medical need?
|
Malar J
|
2012
|
0.98
|
|
20
|
Population pharmacokinetic and pharmacodynamic modelling of the antimalarial chemotherapy chlorproguanil/dapsone.
|
Br J Clin Pharmacol
|
2006
|
0.98
|
|
21
|
Clinical features of severe malaria associated with death: a 13-year observational study in the Gambia.
|
PLoS One
|
2012
|
0.95
|
|
22
|
Mortality patterns and site heterogeneity of severe malaria in African children.
|
PLoS One
|
2013
|
0.94
|
|
23
|
Early phase clinical trials with human immunodeficiency virus-1 and malaria vectored vaccines in The Gambia: frontline challenges in study design and implementation.
|
Am J Trop Med Hyg
|
2014
|
0.86
|
|
24
|
Combining community case management and intermittent preventive treatment for malaria.
|
Trends Parasitol
|
2011
|
0.85
|
|
25
|
Malaria Prevalence among Young Infants in Different Transmission Settings, Africa.
|
Emerg Infect Dis
|
2015
|
0.84
|
|
26
|
Neonatal admissions, quality of care and outcome: 4 years of inpatient audit data from The Gambia's teaching hospital.
|
Paediatr Int Child Health
|
2015
|
0.83
|
|
27
|
A comparative case control study of the determinants of clinical malaria in The Gambia.
|
Malar J
|
2014
|
0.81
|
|
28
|
Community-based scheduled screening and treatment of malaria in pregnancy for improved maternal and infant health in The Gambia, Burkina Faso and Benin: study protocol for a randomized controlled trial.
|
Trials
|
2014
|
0.81
|
|
29
|
Knowing who to trust: exploring the role of 'ethical metadata' in mediating risk of harm in collaborative genomics research in Africa.
|
BMC Med Ethics
|
2014
|
0.78
|
|
30
|
Use of artemisinin and its derivatives for the treatment of malaria in children.
|
Pediatr Infect Dis J
|
2014
|
0.77
|